SAFETY, TOLERABILITY, AND PHARMACOLOGIC ACTIVITY OF MULTIPLE DOSES OF THE NEW PLATELET ACTIVATING FACTOR ANTAGONIST WEB-2086 IN HUMAN-SUBJECTS

被引:32
作者
ADAMUS, WS [1 ]
HEUER, H [1 ]
MEADE, CJ [1 ]
BRECHT, HM [1 ]
机构
[1] BOEHRINGER INGELHEIM KG,DEPT PHARMACOL,D-6507 INGELHEIM,FED REP GER
关键词
D O I
10.1038/clpt.1989.27
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:270 / 276
页数:7
相关论文
共 31 条
[1]  
ADAMUS WS, 1988, EUR J CLIN PHARMACOL, V35, P237
[2]  
ARNOUT J, 1987, THROMB HAEMOSTASIS, V58, P20
[3]  
ARNOUX B, 1987, B EUR PHYSIOPATH RES, V23, P119
[4]  
BORN GVR, 1963, J PHYSIOL-LONDON, V168, P178, DOI 10.1113/jphysiol.1963.sp007185
[5]  
BRAMBILLA A, 1987, PHARMACOL RES, V19, P147
[6]  
BRAQUET P, 1987, PHARMACOL REV, V39, P97
[7]  
Casals-Stenzel J, 1988, Prog Biochem Pharmacol, V22, P58
[8]   EFFECTS OF WEB-2086, A NOVEL ANTAGONIST OF PLATELET-ACTIVATING-FACTOR, IN ACTIVE AND PASSIVE ANAPHYLAXIS [J].
CASALSSTENZEL, J .
IMMUNOPHARMACOLOGY, 1987, 13 (02) :117-124
[9]   TRIAZOLODIAZEPINES - DISSOCIATION OF THEIR PAF (PLATELET-ACTIVATING-FACTOR) ANTAGONISTIC AND CNS ACTIVITY [J].
CASALSSTENZEL, J ;
WEBER, KH .
BRITISH JOURNAL OF PHARMACOLOGY, 1987, 90 (01) :139-146
[10]  
CASALSSTENZEL J, 1987, J PHARMACOL EXP THER, V241, P974